228
Views
19
CrossRef citations to date
0
Altmetric
Research Article

The effect of ursodeoxycholic acid on oxidative stress level and DNase activity in rat liver after bile duct ligation

, , , , , , , & show all
Pages 141-148 | Received 30 May 2011, Accepted 16 Jan 2012, Published online: 02 Mar 2012

References

  • Aksu, B., Umit, H., Kanter, M., Guzel, A., Aktas, C., Civelek, S., et al. (2010). Effects of methylene blue in reducing cholestatic oxidative stress and hepatic damage after bile-duct ligation in rats. Acta Histochem 112:259–269.
  • Alvaro, D., Benedetti, A., Marucci, L., Delle Monache, M., Monterubbianesi, R., Di Cosimo, E., et al. (2000). The function of alkaline phosphatase in the liver: regulation of intrahepatic biliary epithelium secretory activities in the rat. Hepatology 32:174–184.
  • Azzaroli, F., Mehal, W., Soroka, C. J., Wang, L., Lee, J., Crispe, N., et al. (2002). Ursodeoxycholic acid diminishes Fas-ligand-induced apoptosis in mouse hepatocytes. Hepatology 36:49–54.
  • Barón, V., Muriel, P. (1999). Role of glutathione, lipid peroxidation, and antioxidants on acute bile-duct obstruction in the rat. Biochim Biophys Acta 1472:173–180.
  • Bartholeyns, J., Peeters-Joris, C., Reychler, H., Baudhun, P. (1975). Hepatic nucleases 1. Method for the specific determination and characterization in rat liver. Eur J Biochem 57:205–211.
  • Canbay, A., Higuchi, H., Bronk, S. F., Taniai, M., Sebo, T. J., Gores, G. J. (2002). Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis. Gastroenterology 123:1323–1330.
  • Demirbilek, S., Akin, M., Gürünlüoğlu, K., Aydin, N. E., Emre, M. H., Taş, E., et al. (2006). The NF-kappaB inhibitors attenuate hepatic injury in bile duct ligated rats. Pediatr Surg Int 22:655–663.
  • Forman, H. J., Torres, M. (2002). Reactive oxygen species and cell signaling: respiratory burst in macrophage signaling. Am J Respir Crit Care Med 166:S4–S8.
  • Glinghammar, B., Inoue, H., Rafter, J. J. (2002). Deoxycholate causes DNA damage in colonic cells with subsequent induction of caspases, COX-2 promoter activity, and the transcription factors NF-kB and AP-1. Carcinogenesis 23:839–845.
  • Goth, L. (1991). A simple method for determination of serum catalase activity and revision of reference range. Clin Chim Acta 196:143–151.
  • Graf, D., Kurz, A. K., Fischer, R., Reinehr, R., Haussinger, D. (2002). Taurolithocholic acid-3 sulfate induces CD95 trafficking and apoptosis in a c-Jun N-terminal kinase-dependent manner. Gastroenterology 122:1411–1427.
  • Hagey, L. R., Crombie, D. L., Espinosa, E., Carey, M. C., Igimi, H., Hofmann, A. F. (1993). Ursodeoxycholic acid in the Ursidae: biliary bile acids of bears, pandas, and related carnivores. J Lipid Res 34:1911–1917.
  • Hashimoto, S. (1974). A new spectrophotometric assay method of xanthine oxidase in crude tissue homogenate. Anal Biochem 62:426–435.
  • Huang, Y. T., Hsu, Y. C., Chen, C. J., Liu, C. T., Wei, Y. H. (2003). Oxidative-stress-related changes in the livers of bile-duct-ligated rats. J Biomed Sci 10:170–178.
  • Krähenbühl, S., Fischer, S., Talos, C., Reichen, J. (1994). Ursodeoxycholate protects oxidative mitochondrial metabolism from bile acid toxicity: dose-response study in isolated rat liver mitochondria. Hepatology 20:1595–1601.
  • Kullak-Ublick, G. A., Maier, P. J. (2000). Mechanisms of cholestasis. Clin Liver Dis 4:357–385.
  • Lapenna, D., Ciofani, G., Festi, D., Neri, M., Pierdomenico, S. D., Giamberardino, M. A., et al. (2002). Antioxidant properties of ursodeoxycholic acid. Biochem Pharmacol 64:1661–1667.
  • Lazaridis, K. N., Gores, G. J., Lindor, K. D. (2001). Ursodeoxycholic acid mechanisms of action and clinical use in hepatobiliary disorders. J Hepatol 35:134–146.
  • Lee, T. Y., Chang, H. H., Chen, J. H., Hsueh, M. L., Kuo, J. J. (2007). Herb medicine Yin-Chen-Hao-Tang ameliorates hepatic fibrosis in bile duct ligation rats. J Ethnopharmacol 109:318–324.
  • Levine, R. L., Williams, J. A., Stadtman, E. R., Shacter, E. (1994). Carbonyl assay for determination of oxidatively modified proteins. Methods Enzymol 233:346–357
  • Ljubuncic, P., Abu-Salach, O., Bomzon, A. (2005). Ursodeoxycholic acid and superoxide anion. World J Gastroenterol 11:4875–4878.
  • Ljubuncic, P., Fuhrman, B., Oiknine, J., Aviram, M., Bomzon, A. (1996). Effect of deoxycholic acid and ursodeoxycholic on lipid peroxidation in cultured macrophages. Gut 39:475–478.
  • Ljubuncic, P., Tanne, Z., Bomzon, A. (2000). Ursodeoxycholic acid suppresses extent of lipid peroxidation in diseased liver in experimental cholestatic liver disease. Dig Dis Sci 45:1921–1928.
  • Lowry, O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J. (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275.
  • Mashige, F., Tanaka, N., Maki, A., Kamei, S., Yamanaka, M. (1981). Direct spectrophotometry of total bile acids in serum. Clin Chem 27:1352–1356.
  • Meneshian, A., Bulkley, G. B. (2002). The physiology of endothelial xanthine oxidase: from urate catabolism to reperfusion injury to inflammatory signal transduction. Microcirculation 9:161–175.
  • Mitsuyoshi, H., Nakashima, T., Sumida, Y., Yoh, T., Nakajima, Y., Ishikawa, H., et al. (1999). Ursodeoxycholic acid protects hepatocytes against oxidative injury via induction of antioxidants. Biochem Biophys Res Commun 263:537–542.
  • Moskovitz, J., Yim, M. B., Chock, P. B. (2002). Free radicals and disease. Arch Biochem Biophys 397:354–359.
  • Mukae, N., Enari, M., Sakahira, H., Fukuda, Y., Inazawa, J., Toh, H., et al. (1998). Molecular cloning and characterization of human caspase-activated DNase. Proc Natl Acad Sci U S A 95:9123–9128.
  • Murrell, G. A., Francis, M. J., Bromley, L. (1990). Modulation of fibroblast proliferation by oxygen free radicals. Biochem J 265:659–665.
  • Nishino, T., Okamoto, K., Kawaguchi, Y., Hori, H., Matsumura, T., Eger, B. T., et al. (2005). Mechanism of the conversion of xanthine dehydrogenase to xanthine oxidase: identification of the two cysteine disulfide bonds and crystal structure of a non-convertible rat liver xanthine dehydrogenase mutant. J Biol Chem 280:24888–24894.
  • Ohkawa, H., Ohishi, N., Yagi, K. (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358.
  • Oliveri, M., Daga, A., Cantoni, C., Lunardi, C., Millo, R., Puccetti, A. (2001). DNase I mediates internucleosomal DNA degradation in human cells undergoing drug-induced apoptosis. Eur J Immunol 31:743–751.
  • Orellana, M., Rodrigo, R., Thielemann, L., Guajardo, V. (2000). Bile duct ligation and oxidative stress in the rat: effects in liver and kidney. Comp Biochem Physiol C Toxicol Pharmacol 126:105–111.
  • Poli, G., Parola, M., Leonarduzzi, G., Pinzani, M. (1993). Modulation of hepatic fibrogenesis by antioxidants. Mol Aspects Med 14:259–264.
  • Poupon, R., Poupon, R. E. (1995). Ursodeoxycholic acid therapy of chronic cholestatic conditions in adults and children. Pharmacol Ther 66:1–15.
  • Qiao, L., Yacoub, A., Studer, E., Gupta, S., Pei, X. Y., Grant, S., et al. (2002). Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytes. Hepatology 35:779–789.
  • Rosser, B. G., Gores, G. J. (1995). Liver cell necrosis: cellular mechanisms and clinical implications. Gastroenterology 108:252–275.
  • Saksena, S., Tandon, R. K. (1997). Ursodeoxycholic acid in the treatment of liver diseases. Postgrad Med J 73:75–80.
  • Schimpl, G., Pesendorfer, P., Kuesz, A. M., Ratschek, M., Höllwarth, M. E. (2000). The impact of hepatic xanthine oxidase and xanthine dehydrogenase activities on liver function in chronic cholestasis. Pediatr Surg Int 16:297–301.
  • Schmucker, D. L., Ohta, M., Kanai, S., Sato, Y., Kitani, K. (1990). Hepatic injury induced by bile salts: correlation between biochemical and morphological events. Hepatology 12:1216–1221.
  • Serviddio, G., Pereda, J., Pallardó, F. V., Carretero, J., Borras, C., Cutrin, J., et al. (2004). Ursodeoxycholic acid protects against secondary biliary cirrhosis in rats by preventing mitochondrial oxidative stress. Hepatology 39:711–720.
  • Sodeman, T., Bronk, S. F., Roberts, P. J., Miyoshi, H., Gores, G. J. (2000). Bile salts mediate hepatocyte apoptosis by increasing cell surface trafficking of Fas. Am J Physiol Gastrointest Liver Physiol 278:G992–G999.
  • Sokol, R. J., Devereaux, M. W., Khandwala, R. (1998). Effect of oxypurinol, a xanthine oxidase inhibitor, on hepatic injury in the bile duct-ligated rat. Pediatr Res 44:397–401.
  • Sokol, R. J., McKim, J. M. Jr., Goff, M. C., Ruyle, S. Z., Devereaux, M. W., Han, D., et al. (1998). Vitamin E reduces oxidant injury to mitochondria and the hepatotoxicity of taurochenodeoxycholic acid in the rat. Gastroenterology 114:164–174.
  • Sokolovic, D., Bjelakovic, G., Nikolic, J., Djindjic, B., Pavlovic, D., Kocic, G., et al. (2010). Effect of L-arginine on metabolism of polyamines in rat’s brain with extrahepatic cholestasis. Amino Acids 38:339–345.
  • Sokolovic, D., Djindjic, B., Nikolic, J., Bjelakovic, G., Pavlovic, D., Kocic, G., et al. (2008). Melatonin reduces oxidative stress induced by chronic exposure of microwave radiation from mobile phones in rat brain. J Radiat Res 49:579–586.
  • Terao, M., Cazzaniga, G., Ghezzi, P., Bianchi, M., Falciani, F., Perani, P., et al. (1992). Molecular cloning of a cDNA coding for mouse liver xanthine dehydrogenase. Regulation of its transcript by interferons in vivo. Biochem J 283:863–870.
  • Trauner, M., Meier, P. J., Boyer, J. L. (1998). Molecular pathogenesis of cholestasis. N Engl J Med 339:1217–1227.
  • Wang, G., Shen, H., Rajaraman, G., Roberts, M. S., Gong, Y., Jiang, P., et al. (2007). Expression and antioxidant function of liver fatty acid binding protein in normal and bile-duct ligated rats. Eur J Pharmacol 560:61–68.
  • Yerushalmi, B., Dahl, R., Devereaux, M. W., Gumpricht, E., Sokol, R. J. (2001). Bile acid-induced rat hepatocyte apoptosis is inhibited by antioxidants and blockers of the mitochondrial permeability transition. Hepatology 33:616–626.
  • Yu, B. P. (1994). Cellular defenses against damage from reactive oxygen species. Physiol Rev 74:139–162.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.